Share Email Print
cover

Proceedings Paper

Efficacy of pyropheophorbide-a-hexyl ether for photodynamic therapy of rat 9L gliosarcoma
Author(s): Susan A. Autry-Conwell; Benjamin F. Edwards; James E. Boggan; Regina Gandour-Edwards; Ravindra K. Pandey; Thomas J. Dougherty
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

In preliminary studies, the efficacy of a new photosensitizer, pyropheophorbide-(alpha) - hexyl ether (HPPH #23), for use in photodynamic therapy (PDT) was assessed using the rat 9L gliosarcoma tumor model in subcutaneous flank tumors, intracranial tumors, and in vivo. Flank and intracranial tumors were irradiated with 75 - 203 J/cm2 24 hours after 0.3 - 0.6 mg/kg IV injection of HPPH #23. At 24 hours post-PDT, and flank tumors showed a range of necrosis at the highest laser dose from 50 - 100%. The overlying skin and underlying muscle were spared. Intracranial tumors exhibited moderate to severe hemorrhagic necrosis. Areas of brain adjacent to tumor within the irradiated field also showed some damage. In vitro phototoxicity of HPPH #23 was compared to that of Photofrin II (PhII). Cells growing in culture dishes were exposed to HPPH #23 or PhII for 20 hours, washed free of unbound drug, then irradiated at 2.5 J/cm2, 17 mW/cm2 at 665 nm (HPPH #23) or 630 nm (PhII). Irradiated cultures were maintained in dark incubators for an additional 4 - 5 days, and phototoxic inhibition of cell proliferation was quantified by the sulphorhodamine B spectrophotometric assay. Under identical irradiation conditions, the IC50 for HPPH #23 (0.25 (mu) g/ml) was 10-fold lower than that of PhII (2.5 (mu) g/ml). Complete cell kill was achieved at sensitizer doses of 0.5 (mu) g/ml (HPPH #23) and 5.0 (mu) g/ml (PhII).

Paper Details

Date Published: 18 June 1993
PDF: 11 pages
Proc. SPIE 1881, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy II, (18 June 1993); doi: 10.1117/12.146298
Show Author Affiliations
Susan A. Autry-Conwell, Univ. of California/Davis School of Medicine (United States)
Benjamin F. Edwards, Ctr. for Companion Animal Health (United States)
James E. Boggan, Univ. of California/Davis School of Medicine (United States)
Regina Gandour-Edwards, Univ. of California/Davis Medical Ctr. (United States)
Ravindra K. Pandey, Roswell Park Cancer Institute (United States)
Thomas J. Dougherty, Roswell Park Cancer Institute (United States)


Published in SPIE Proceedings Vol. 1881:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy II
Thomas J. Dougherty, Editor(s)

© SPIE. Terms of Use
Back to Top